219 related articles for article (PubMed ID: 7454962)
1. [Study of the binding between uric acid and plasma proteins (author's transl)].
Sforza GR; Marcolongo R; Della Fazia L; Masciangelo F; Morozzi G; Lo Cosmo C
Quad Sclavo Diagn; 1980 Dec; 15(4):1075-89. PubMed ID: 7454962
[TBL] [Abstract][Full Text] [Related]
2. [Studies on plasma protein binding of uric acid in gout].
Holländer E
Acta Med Acad Sci Hung; 1973; 30(4):241-9. PubMed ID: 4792224
[No Abstract] [Full Text] [Related]
3. The binding of urate to plasma proteins determined by means of equilibrium dialysis.
Klinenberg JR; Kippen I
J Lab Clin Med; 1970 Mar; 75(3):503-10. PubMed ID: 5416905
[No Abstract] [Full Text] [Related]
4. Hereditary nephropathy associated with hyperuricemia and gout.
Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
[TBL] [Abstract][Full Text] [Related]
5. The binding of urate to plasma proteins determined by four different techniques.
Hardwell TR; Manley G; Braven J; Whittaker M
Clin Chim Acta; 1983 Sep; 133(1):75-83. PubMed ID: 6354516
[TBL] [Abstract][Full Text] [Related]
6. [Familial gout and nephropathy in a young woman. Report of one case].
Badilla A; Rojas C
Rev Med Chil; 2001 Jun; 129(6):666-70. PubMed ID: 11510209
[TBL] [Abstract][Full Text] [Related]
7. Protein binding of urate ions in vitro and in vivo.
Farrell PC
Prog Biochem Pharmacol; 1974; 9():153-62. PubMed ID: 4438377
[No Abstract] [Full Text] [Related]
8. The binding of urate to plasma proteins.
Klinenberg JR; Bluestone R; Campion D; Whitehouse M
Adv Exp Med Biol; 1974; 41():557-66. PubMed ID: 4832582
[No Abstract] [Full Text] [Related]
9. [Extracorporeal uric clearance for the demonstration of in vivo bound uric acid].
Wolf A; Stummvoll HK; Müller MM; Pinggera WF
Acta Med Austriaca; 1977; 4(5):193-5. PubMed ID: 613700
[TBL] [Abstract][Full Text] [Related]
10. [Uptake of 2-C14 urate by erythrocytes in hyperuricemia and in gout (author's transl)].
Lang F; Greger R; Silbernagel H; Günther R; Deetjen P
Klin Wochenschr; 1978 Mar; 53(16):261-4. PubMed ID: 682521
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of hyperuricemia caused by fructose in a status of altered uric acid metabolism].
Menghini S; Della Corte E
Quad Sclavo Diagn; 1987 Dec; 23(4):441-6. PubMed ID: 3509875
[TBL] [Abstract][Full Text] [Related]
12. [Clinical picture of gout and gouty (hyperuricemic) kidney].
Sosovec V
Vnitr Lek; 1975 Aug; 21(8):808-12. PubMed ID: 1162915
[No Abstract] [Full Text] [Related]
13. Altered uric acid levels and disease states.
Kutzing MK; Firestein BL
J Pharmacol Exp Ther; 2008 Jan; 324(1):1-7. PubMed ID: 17890445
[TBL] [Abstract][Full Text] [Related]
14. [Arterial hypertension in gouty nephropathy].
Gocheva V; Atanasova P
Vutr Boles; 1986; 25(3):56-9. PubMed ID: 3765579
[TBL] [Abstract][Full Text] [Related]
15. [Elevated serum uric acid in a normal population and in patients (author's transl)].
Hägeli S; Burke C; Scholer A
Schweiz Rundsch Med Prax; 1981 Nov; 70(47):2124-8. PubMed ID: 7312816
[No Abstract] [Full Text] [Related]
16. Characteristics of serum protein binding of felodipine.
Valle M; Esteban M; Rodríguez-Sasiaín JM; Calvo R; Aguirre C
Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):73-88. PubMed ID: 8948016
[TBL] [Abstract][Full Text] [Related]
17. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP; Leung KT; Tong MK; Kwan TH
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[TBL] [Abstract][Full Text] [Related]
18. Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.
Panomvana D; Sripradit S; Angthararak S
J Clin Rheumatol; 2008 Feb; 14(1):6-11. PubMed ID: 18431090
[TBL] [Abstract][Full Text] [Related]
19. [The gouty kidney].
Lagrue G
Rev Prat; 1983 Oct; 33(43):2263-8. PubMed ID: 6635504
[No Abstract] [Full Text] [Related]
20. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]